Seres Therapeutics Inc. (MCRB) Statistics & Valuation Metrics - Stocknear

Seres Therapeutics Inc.

NASDAQ: MCRB · Real-Time Price · USD
19.36
0.56 (2.98%)
At close: Sep 05, 2025, 3:59 PM
19.32
-0.23%
After-hours: Sep 05, 2025, 05:40 PM EDT

Seres Therapeutics Statistics

Share Statistics

Seres Therapeutics has 8.75M shares outstanding. The number of shares has increased by 0.27% in one year.

8.75M
0.27%
0.17%
35.26%
6.45M
9,122
7.23%

Short Selling Information

The latest short interest is 1.03M, so 11.82% of the outstanding shares have been sold short.

1.03M
11.82%
19.2%
8.45

Valuation Ratios

The PE ratio is 18990.89 and the forward PE ratio is -1.85. Seres Therapeutics's PEG ratio is -189.72.

18990.89
-1.85
0
6.8
187.37
-17.34
-189.72
Financial Ratio History

Enterprise Valuation

Seres Therapeutics has an Enterprise Value (EV) of 2.64B.

0
-23.8
-17.79
-17.74

Financial Position

The company has a current ratio of 0.94, with a Debt / Equity ratio of 6.65.

0.94
0.94
6.65
-0.83
-0.62
0

Financial Efficiency

Return on Equity is 0.99% and Return on Invested Capital is -104.64%.

0.99%
0.1%
-104.64%
n/a
$1.32K
103
0
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by 1.47% in the last 52 weeks. The beta is 0.16, so Seres Therapeutics's price volatility has been higher than the market average.

0.16
1.47%
14.86
13.63
63.93
126,143

Income Statement

n/a
-14.7M
-121.31M
136K
-111.07M
-125.77M
0
Full Income Statement

Balance Sheet

The company has 30.79M in cash and 91.64M in debt, giving a net cash position of -60.85M.

30.79M
91.64M
-60.85M
-978.1M
143.8M
17.75M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -148.61M and capital expenditures -380K, giving a free cash flow of -148.99M.

-148.61M
-380K
-148.99M
-0.96
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

MCRB does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
0.01%
-5.77%
Dividend Details

Analyst Forecast

The average price target for MCRB is $15, which is -22.5% lower than the current price. The consensus rating is "Hold".

$15
-22.5%
Hold
4
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
0.04
-99.79%

Stock Splits

The last stock split was on Apr 22, 2025. It was a backward split with a ratio of 1:20.

Apr 22, 2025
backward
1:20

Scores

-10.95
5